Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02361320 · ClinicalTrials.gov registry record · NA
Computed Tomography in Diagnosing Patients With Pancreatic or Hepatobiliary Cancer
A NA study of Pancreatic Cancer, sponsored by M.D. Anderson Cancer Center.
- Recruiting
- Registry status
- NA
- Development phase
- 259
- Enrollment target
- 1
- Study location
NCT02361320 is a NA study of Pancreatic Cancer that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 259 participants, below the 392-participant average among 278 other Pancreatic Cancer trials with a reported enrollment target (34% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02361320, a NA study of Pancreatic Cancer, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 259 participants
- Enrollment target
- 1
- Study location
Study Summary
This trial studies how well computed tomography works in diagnosing patients with pancreatic or hepatobiliary cancer. Computed tomography may help researchers predict how patients with pancreatic or hepatobiliary cancer may respond to chemotherapy.
Conditions Studied
Interventions
- PROCEDURE Computed Tomography (CT)
- BEHAVIORAL Questionnaire
Study Locations (1)
Texas
- M D Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 259 participants |
| Start Date | 2015-03-09 |
| Est. Completion | 2026-06-27 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02361320
The ClinicalTrials.gov registry entry for NCT02361320 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 259 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 392-participant average among 278 other Pancreatic Cancer trials with a reported enrollment target (34% lower). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Pancreatic Cancer appearing as the primary indexed condition, and to 2 interventions - of which Computed Tomography (CT) is the first listed.
NCT02361320 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT02361320 about?
NCT02361320 is a clinical study titled "Computed Tomography in Diagnosing Patients With Pancreatic or Hepatobiliary Cancer". This trial studies how well computed tomography works in diagnosing patients with pancreatic or hepatobiliary cancer. Computed tomography may help researchers predict how patients with pancreatic or hepatobiliary cancer may respond to chemotherapy.
What is the current status of trial NCT02361320?
This trial is currently recruiting. It is a NA study. The enrollment target is 259 participants. The study started on 2015-03-09. Estimated completion is 2026-06-27.
What conditions does trial NCT02361320 study?
This clinical trial studies the following conditions: Pancreatic Cancer.
What interventions are being tested in trial NCT02361320?
The interventions under investigation include: Computed Tomography (CT) (PROCEDURE), Questionnaire (BEHAVIORAL).
Who is sponsoring clinical trial NCT02361320?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02361320 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pancreatic Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Alpha Radiation Emitters Device for the Treatment of Pancreatic Cancer With Chemotherapy for the Treatment of Locally Advanced and Metastatic Pancreatic Cancer
RECRUITING · NA
-
A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue
RECRUITING · NA
-
EUS Examination Using EndoSound Vision System vs. Standard Echoendoscope
RECRUITING · NA
-
Support Through Remote Observation and Nutrition Guidance Program (STRONG-PCS)
RECRUITING · NA
-
GENOCARE: A Prospective, Randomized Clinical Trial of Genotype-Guided Dosing Versus Usual Care
RECRUITING · NA
-
Resistance Exercise Combined With Protein Supplementation in People With Pancreatic Cancer: The RE-BUILD Trial
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.